India's Wockhardt jumps; US FDA accepts application for antibiotic Zaynich
ReutersDec 1, 2025 6:31 AM
India's Wockhardt WCKH.NS surges 11.8% to 1,380.80 rupees
Drugmaker says US FDA accepts its new drug application for antibiotic Zaynich
Zaynich also gets fast track designation by US FDA, assigning priority to its application's review
YTD, WCKH down 2.6%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
US Q3 GDP Released, Will US Stocks See a "Santa Claus Rally"?【The week ahead】
TradingKey - This week, global financial markets will enter "Christmas mode." Investors should focus on US GDP data, and Bank of Japan Governor Kazuo Ueda will deliver a speech, potentially offering clues on the interest rate trajectory for 2026.TradingKey
16 hours ago
Rocket Lab Stock Analysis: Why Is Rocket Lab Stock Price Soaring? Is Now a Good Time To Buy?
TradingKey - Even though Rocket Lab's stock price has seen substantial gains from its previous levels, we believe that Rocket Lab still offers speculative value.TradingKey
Mon, Dec 22
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Is This the Gray Rhino Scarier Than Fed Rate Hikes? What Yen Rate Hikes Mean for Global Liquidity
TradingKey - Japan, an economy with government debt surpassing 250% of GDP, stands at the precipice where policy contradictions threaten market collapse.TradingKey
Wed, Dec 10
Why Did Strategy's Stock Price Plummet? Can MSTR Reach $1,000?
MicroStrategy (MSTR) stock, despite pressures from Bitcoin volatility and its weak core business, represents the most leveraged investment in a Bitcoin bull market. The company's stock path to $1,000 largely depends on Bitcoin's market performance. Major institutions, including Standard Chartered anTradingKey
Thu, Dec 4
Tradingkey
